LimFlow

LimFlow is a venture-backed private medical device company dedicated to transforming the treatment of chronic limb-threatening ischemia, with growing clinical demand driven by the epidemics of diabetes, heart disease, kidney disease, and an aging population.When all other treatment options have been exhausted and CLTI patients are facing major amputation, the minimally invasive LimFlow system is designed to bypass blocked arteries in the leg and deliver oxygenated blood back to the foot through veins. For many patients, restoring perfusion to the lower extremities can alleviate chronic pain, improve quality of life, promote wound healing, and prevent major amputation.